OpenBilldrug price receipt

NADAC week of 2026-10-14

MIRVASO 0.33% GEL PUMP

FDA nonproprietary name: brimonidine tartrate

For 30 g

Pharmacies pay

$643.98 filed

30 × $21.46607 per GM

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$617.44 filed

30 × $20.58117 per GM, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.96× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Mirvaso” / “Brimonidine Tartrate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-08-19 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$745.58 estimated

$643.98 + $96.60 (15%) + $5.00 fee per fill = $745.58

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-08-19 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

MIRVASO 0.33% GEL PUMP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as brimonidine tartrate, under the trade name “Mirvaso”.

FDA gives its dosage form as gel and its route as topical.

The labeler, the company named on the label, is Galderma Laboratories, L.P.

FDA’s Established Pharmacologic Class for it is alpha-Adrenergic Agonist.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00299-5980-35.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $643.98 for 30 g (30 × $21.46607 per GM, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-08-19. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-08-19. The file is new; the price is not.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $13.92613 per GM filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

6 other products in the NADAC file share the FDA nonproprietary name brimonidine tartrate with MIRVASO 0.33% GEL PUMP.

ProductPharmacies pay per unitMedicare per unit
ALPHAGAN P 0.1% DROPS
brand · solution/ drops
$37.25406 to $37.35499 per ML filed
eff. 2026-09-23
$37.44191 per ML filed
Part D 2024 average
ALPHAGAN P 0.15% EYE DROPS
brand · solution/ drops
$39.74875 to $39.84933 per ML filed
eff. 2026-09-23
$37.44191 per ML filed
Part D 2024 average
BRIMONIDINE 0.2% EYE DROP
generic · solution/ drops / solution
$0.50116 to $0.85299 per ML filed
eff. 2026-09-23 to 2026-09-30
$3.90369 per ML filed
Part D 2024 average
BRIMONIDINE TARTRATE 0.1% DROP
generic · solution/ drops
$6.5539 to $10.51982 per ML filed
eff. 2026-09-23
$3.90369 per ML filed
Part D 2024 average
BRIMONIDINE TARTRATE 0.15% DRP
generic · solution/ drops / solution
$9.74729 to $11.65198 per ML filed
eff. 2026-09-23
$3.90369 per ML filed
Part D 2024 average
LUMIFY 0.025% EYE DROP
brand · solution/ drops
$1.99701 to $3.42973 per ML filed
eff. 2026-08-19 to 2026-09-23
We don’t know yet
MIRVASO 0.33% GEL PUMP this page
brand · gel
$21.46607 per GM filed
eff. 2026-08-19
$20.58117 per GM filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $617.44 for 30 g, at an average of $20.58117 per GM in 2024 (2024-01-01 to 2024-12-31) for “Mirvaso” and “Brimonidine Tartrate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 586 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for MIRVASO 0.33% GEL PUMP labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Mirvaso / Brimonidine Tartrate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's GM. Joined on brand name.
Why does this page start at 30 g?
NADAC prices this product per GM. The FDA NDC Directory’s package description gives 30 g in one package for this product’s NDC (“1 BOTTLE, PUMP in 1 CARTON (0299-5980-35) / 30 g in 1 BOTTLE, PUMP”), so the card starts at one package: 30 GM. Change it to match your prescription.